Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jerry Avorn

Showing results (251-260 of 308) with videos related to

Pageof 31
Sort By:
Journal of General Internal Medicine|October 9, 2013
Trends in insulin initiation and treatment intensification among patients with type 2 diabetesAmanda R Patrick, Michael A Fischer, Niteesh K Choudhry, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 25, 2007
Osteoporosis improvement: a large-scale randomized controlled trial of patient and primary care physician educationDaniel H Solomon, Jeffrey N Katz, Joel S Finkelstein, et al.
Journal of General Internal Medicine|July 25, 2007
Patient, physician, pharmacy, and pharmacy benefit design factors related to generic medication useWilliam H Shrank, Margaret Stedman, Susan L Ettner, et al.
Drug Safety|February 19, 2022
New Drug Postmarketing Requirements and Commitments in the US: A Systematic Review of the EvidenceOsman Moneer, Beatrice L Brown, Jerry Avorn, et al.
The American Journal of Medicine|October 25, 2011
Trouble getting started: predictors of primary medication nonadherenceMichael A Fischer, Niteesh K Choudhry, Gregory Brill, et al.
Circulation. Cardiovascular Quality and Outcomes|March 5, 2024
Patient Characteristics Associated With Using Transcatheter Left Atrial Appendage Occlusion Versus Oral Anticoagulants for Atrial FibrillationKueiyu Joshua Lin, Daniel E Singer, Jerry Avorn, et al.
Arthritis and Rheumatism|September 2, 2006
Tumor necrosis factor alpha antagonist use and cancer in patients with rheumatoid arthritisSoko Setoguchi, Daniel H Solomon, Michael E Weinblatt, et al.
The American Journal of Medicine|March 26, 2011
The consequences of requesting "dispense as written"William H Shrank, Joshua N Liberman, Michael A Fischer, et al.
The American Journal of Medicine|February 21, 2012
Patterns of medication initiation in newly diagnosed diabetes mellitus: quality and cost implicationsNihar R Desai, William H Shrank, Michael A Fischer, et al.
Health Affairs (Project Hope)|February 14, 2014
Five features of value-based insurance design plans were associated with higher rates of medication adherenceNiteesh K Choudhry, Michael A Fischer, Benjamin F Smith, et al.
Pageof 31

Showing results (251-260 of 308) with videos related to

Sort By:
Pageof 31
Journal of General Internal Medicine|October 9, 2013
Trends in insulin initiation and treatment intensification among patients with type 2 diabetesAmanda R Patrick, Michael A Fischer, Niteesh K Choudhry, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 25, 2007
Osteoporosis improvement: a large-scale randomized controlled trial of patient and primary care physician educationDaniel H Solomon, Jeffrey N Katz, Joel S Finkelstein, et al.
Journal of General Internal Medicine|July 25, 2007
Patient, physician, pharmacy, and pharmacy benefit design factors related to generic medication useWilliam H Shrank, Margaret Stedman, Susan L Ettner, et al.
Drug Safety|February 19, 2022
New Drug Postmarketing Requirements and Commitments in the US: A Systematic Review of the EvidenceOsman Moneer, Beatrice L Brown, Jerry Avorn, et al.
The American Journal of Medicine|October 25, 2011
Trouble getting started: predictors of primary medication nonadherenceMichael A Fischer, Niteesh K Choudhry, Gregory Brill, et al.
Circulation. Cardiovascular Quality and Outcomes|March 5, 2024
Patient Characteristics Associated With Using Transcatheter Left Atrial Appendage Occlusion Versus Oral Anticoagulants for Atrial FibrillationKueiyu Joshua Lin, Daniel E Singer, Jerry Avorn, et al.
Arthritis and Rheumatism|September 2, 2006
Tumor necrosis factor alpha antagonist use and cancer in patients with rheumatoid arthritisSoko Setoguchi, Daniel H Solomon, Michael E Weinblatt, et al.
The American Journal of Medicine|March 26, 2011
The consequences of requesting "dispense as written"William H Shrank, Joshua N Liberman, Michael A Fischer, et al.
The American Journal of Medicine|February 21, 2012
Patterns of medication initiation in newly diagnosed diabetes mellitus: quality and cost implicationsNihar R Desai, William H Shrank, Michael A Fischer, et al.
Health Affairs (Project Hope)|February 14, 2014
Five features of value-based insurance design plans were associated with higher rates of medication adherenceNiteesh K Choudhry, Michael A Fischer, Benjamin F Smith, et al.
Pageof 31